These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 16492150
41. Synthesis, modelling, and antimitotic properties of tricyclic systems characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole moiety. Pinna GA, Murineddu G, Murruzzu C, Zuco V, Zunino F, Cappelletti G, Artali R, Cignarella G, Solano L, Villa S. ChemMedChem; 2009 Jun; 4(6):998-1009. PubMed ID: 19291736 [Abstract] [Full Text] [Related]
42. Streamlined Symmetrical Total Synthesis of Disorazole B1 and Design, Synthesis, and Biological Investigation of Disorazole Analogues. Nicolaou KC, Krieger J, Murhade GM, Subramanian P, Dherange BD, Vourloumis D, Munneke S, Lin B, Gu C, Sarvaiaya H, Sandoval J, Zhang Z, Aujay M, Purcell JW, Gavrilyuk J. J Am Chem Soc; 2020 Sep 09; 142(36):15476-15487. PubMed ID: 32852944 [Abstract] [Full Text] [Related]
43. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization. Romagnoli R, Baraldi PG, Carrion MD, Lopez Cara C, Preti D, Fruttarolo F, Pavani MG, Tabrizi MA, Tolomeo M, Grimaudo S, Di Cristina A, Balzarini J, Hadfield JA, Brancale A, Hamel E. J Med Chem; 2007 May 03; 50(9):2273-7. PubMed ID: 17419607 [Abstract] [Full Text] [Related]
44. Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and anti-oxidative activity. Vogel S, Ohmayer S, Brunner G, Heilmann J. Bioorg Med Chem; 2008 Apr 15; 16(8):4286-93. PubMed ID: 18343123 [Abstract] [Full Text] [Related]
45. 7,11-epi-thyrsiferol: completion of its synthesis, evaluation of its antimitotic properties, and the further development of an SAR model. Nishiguchi GA, Graham J, Bouraoui A, Jacobs RS, Little RD. J Org Chem; 2006 Aug 04; 71(16):5936-41. PubMed ID: 16872175 [Abstract] [Full Text] [Related]
46. Stilbene derivatives that are colchicine-site microtubule inhibitors have antileukemic activity and minimal systemic toxicity. Cao TM, Durrant D, Tripathi A, Liu J, Tsai S, Kellogg GE, Simoni D, Lee RM. Am J Hematol; 2008 May 04; 83(5):390-7. PubMed ID: 18175355 [Abstract] [Full Text] [Related]
47. Synthesis and biological activity of 7-phenyl-6,9-dihydro-3H-pyrrolo[3,2-f]quinolin-9-ones: a new class of antimitotic agents devoid of aromatase activity. Gasparotto V, Castagliuolo I, Chiarelotto G, Pezzi V, Montanaro D, Brun P, Palù G, Viola G, Ferlin MG. J Med Chem; 2006 Mar 23; 49(6):1910-5. PubMed ID: 16539377 [Abstract] [Full Text] [Related]
48. Natural product-derived modulators of cell cycle progression and viral entry by enantioselective oxa Diels-Alder reactions on the solid phase. Lessmann T, Leuenberger MG, Menninger S, Lopez-Canet M, Müller O, Hümmer S, Bormann J, Korn K, Fava E, Zerial M, Mayer TU, Waldmann H. Chem Biol; 2007 Apr 23; 14(4):443-51. PubMed ID: 17462579 [Abstract] [Full Text] [Related]
49. Synthesis and antitumor activity of cyclodepsipeptide zygosporamide and its analogues. Wang Y, Zhang F, Zhang Y, Liu JO, Ma D. Bioorg Med Chem Lett; 2008 Aug 01; 18(15):4385-7. PubMed ID: 18606540 [Abstract] [Full Text] [Related]
50. Vitamin K3 disrupts the microtubule networks by binding to tubulin: a novel mechanism of its antiproliferative activity. Acharya BR, Choudhury D, Das A, Chakrabarti G. Biochemistry; 2009 Jul 28; 48(29):6963-74. PubMed ID: 19527023 [Abstract] [Full Text] [Related]
51. Microtubule-stabilizing activity of zampanolide, a potent macrolide isolated from the Tongan marine sponge Cacospongia mycofijiensis. Field JJ, Singh AJ, Kanakkanthara A, Halafihi T, Northcote PT, Miller JH. J Med Chem; 2009 Nov 26; 52(22):7328-32. PubMed ID: 19877653 [Abstract] [Full Text] [Related]
52. Synthesis and antiproliferative evaluation of certain pyrido[3,2-g]quinoline derivatives. Li SY, Chen YL, Wang C, Tzeng CC. Bioorg Med Chem; 2006 Nov 15; 14(22):7370-6. PubMed ID: 16887354 [Abstract] [Full Text] [Related]
53. Synthesis and biological evaluation of thiobenzanilides as anticancer agents. Hu WP, Yu HS, Chen YR, Tsai YM, Chen YK, Liao CC, Chang LS, Wang JJ. Bioorg Med Chem; 2008 May 01; 16(9):5295-302. PubMed ID: 18359635 [Abstract] [Full Text] [Related]
54. Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine. Jordan MA, Horwitz SB, Lobert S, Correia JJ. Semin Oncol; 2008 Jun 01; 35(3 Suppl 3):S6-S12. PubMed ID: 18538179 [Abstract] [Full Text] [Related]
55. XN05, a novel synthesized microtubule inhibitor, exhibits potent activity against human carcinoma cells in vitro. Wu R, Ding W, Liu T, Zhu H, Hu Y, Yang B, He Q. Cancer Lett; 2009 Nov 18; 285(1):13-22. PubMed ID: 19647933 [Abstract] [Full Text] [Related]
56. In vitro and in vivo anticancer activities of synthetic (-)-laulimalide, a marine natural product microtubule stabilizing agent. Liu J, Towle MJ, Cheng H, Saxton P, Reardon C, Wu J, Murphy EA, Kuznetsov G, Johannes CW, Tremblay MR, Zhao H, Pesant M, Fang FG, Vermeulen MW, Gallagher BM, Littlefield BA. Anticancer Res; 2007 Nov 18; 27(3B):1509-18. PubMed ID: 17595769 [Abstract] [Full Text] [Related]
57. Natural products as new antimitotic compounds for anticancer drug development. Paier CRK, Maranhão SS, Carneiro TR, Lima LM, Rocha DD, Santos RDS, Farias KM, Moraes-Filho MO, Pessoa C. Clinics (Sao Paulo); 2018 Dec 10; 73(suppl 1):e813s. PubMed ID: 30540125 [Abstract] [Full Text] [Related]
58. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo]. Ji YB, Zhou JH, Zuo MX, You QD. Yao Xue Xue Bao; 2008 Aug 10; 43(8):811-8. PubMed ID: 18956773 [Abstract] [Full Text] [Related]
59. Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SK-OV-3 cells. Choi EJ, Kim T, Lee MS. Life Sci; 2007 Mar 20; 80(15):1403-8. PubMed ID: 17291540 [Abstract] [Full Text] [Related]
60. Cell cycle disturbances and mitotic catastrophes in HeLa Hep2 cells following 2.5 to 10 Gy of ionizing radiation. Eriksson D, Löfroth PO, Johansson L, Riklund KA, Stigbrand T. Clin Cancer Res; 2007 Sep 15; 13(18 Pt 2):5501s-5508s. PubMed ID: 17875782 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]